A Novel Device for Suprachoroidal Drug Delivery to Retina: Evaluation in Nonhuman Primates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Novel Device for Suprachoroidal Drug Delivery to Retina: Evaluation in Nonhuman Primates

Published:2023-06-08 Issue:6 Volume:12 Page:3
ISSN:2164-2591
Container-title:Translational Vision Science & Technology
language:en
Short-container-title:Trans. Vis. Sci. Tech.

Author:

Rotenstreich Ygal¹²³,Sher Ifat¹²⁴,Lawrence Matthew⁵,Mangelus Miriam⁶,Ingerman Avner⁷,Barak Yoreh⁸

Affiliation:

1. The Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel

2. The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

3. Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel

4. TELEM Rubin Excellence in Biomedical Research Program, Sheba Medical Center, Tel Hashomer, Israel

5. Virscio, Inc., New Haven, CT, USA

6. Everads Therapy Ltd., Tel Aviv, Israel

7. AI Consultants, Brookline, MA, USA

8. Department of Ophthalmology, Rambam Health Care Campus, Haifa, Israel

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

Ophthalmology,Biomedical Engineering

Reference45 articles.

1. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the Global Burden of Disease Study;Steinmetz;Lancet Glob Health,2021

2. Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations;Varela-Fernández;Pharmaceutics,2020

3. An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma;Ghanchi;Eye (Lond),2022

4. Visual acuity outcomes and anti–vascular endothelial growth factor therapy intensity in neovascular age-related macular degeneration patients: a real-world analysis of 49?485 eyes;Ciulla;Ophthalmol Retina,2020

5. Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study;Holz;Ophthalmology,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3